Study: Dantrolene Should be Stocked to Control Malignant Hyperthermia for all Anesthetics

Researchers looked at whether or not it was necessary to stock dantrolene, a drug used to treat malignant hyperthermia, at facilities using succinylcholine alone instead of volatile anesthetics, according to Anesthesia-Analgesia.

While the study observed if succinylcholine triggered MH, their methods provided little insight. The risk of MH with versus without succinylcholine both exceeded 1.

Researchers concluded that until more epidemiologic data is collected, having dantrolene available where both succinylcholine and volatile anesthetics are administers should be continued.

More Articles on Anesthesia:
MEDNAX Acquires Tennessee Anesthesia, Texas Pediatric Surgery Practices
Ethnicities Tied to Children's Pain Scores
Class 1 Recall Issued for Ventlab's Manual Resuscitators



Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast